185 related articles for article (PubMed ID: 32566010)
21. Overexpression of caldesmon is associated with tumor progression in patients with primary non-muscle-invasive bladder cancer.
Lee MS; Lee J; Kim JH; Kim WT; Kim WJ; Ahn H; Park J
Oncotarget; 2015 Nov; 6(37):40370-84. PubMed ID: 26430961
[TBL] [Abstract][Full Text] [Related]
22. Systematic screening of protein-coding gene expression identified HMMR as a potential independent indicator of unfavorable survival in patients with papillary muscle-invasive bladder cancer.
Yang D; Ma Y; Zhao P; Ma J; He C
Biomed Pharmacother; 2019 Dec; 120():109433. PubMed ID: 31568988
[TBL] [Abstract][Full Text] [Related]
23. Novel Biomarkers Associated With Progression and Prognosis of Bladder Cancer Identified by Co-expression Analysis.
Wang Y; Chen L; Ju L; Qian K; Liu X; Wang X; Xiao Y
Front Oncol; 2019; 9():1030. PubMed ID: 31681575
[TBL] [Abstract][Full Text] [Related]
24. Prognostic Significance of CREB-Binding Protein and CD81 Expression in Primary High Grade Non-Muscle Invasive Bladder Cancer: Identification of Novel Biomarkers for Bladder Cancer Using Antibody Microarray.
Lee MS; Kim JH; Lee JS; Yun SJ; Kim WJ; Ahn H; Park J
PLoS One; 2015; 10(4):e0125405. PubMed ID: 25915404
[TBL] [Abstract][Full Text] [Related]
25. Role of downregulated miR-133a-3p expression in bladder cancer: a bioinformatics study.
Gao L; Li SH; Tian YX; Zhu QQ; Chen G; Pang YY; Hu XH
Onco Targets Ther; 2017; 10():3667-3683. PubMed ID: 28790856
[TBL] [Abstract][Full Text] [Related]
26. Identification of differentially expressed genes regulated by methylation in colon cancer based on bioinformatics analysis.
Liang Y; Zhang C; Dai DQ
World J Gastroenterol; 2019 Jul; 25(26):3392-3407. PubMed ID: 31341364
[TBL] [Abstract][Full Text] [Related]
27. CALD1 promotes the expression of PD-L1 in bladder cancer via the JAK/STAT signaling pathway.
Li C; Yang F; Wang R; Li W; Maskey N; Zhang W; Guo Y; Liu S; Wang H; Yao X
Ann Transl Med; 2021 Sep; 9(18):1441. PubMed ID: 34733993
[TBL] [Abstract][Full Text] [Related]
28. Predictive value of cadherin-11 for subsequent recurrence and progression in non-muscle invasive bladder cancer.
Chen MK; Chen ZJ; Xiao KH; Qin ZK; Ye YL; Wen WJ; Bian J; Xue KY; Zhou QZ; Guo WB; Zhou JH; Xia M; Li X; Liu CD
Jpn J Clin Oncol; 2020 Apr; 50(4):456-464. PubMed ID: 31894237
[TBL] [Abstract][Full Text] [Related]
29. Identification of key pathways and genes influencing prognosis in bladder urothelial carcinoma.
Ning X; Deng Y
Onco Targets Ther; 2017; 10():1673-1686. PubMed ID: 28356754
[TBL] [Abstract][Full Text] [Related]
30. Identification and Immunocorrelation of Prognosis-Related Genes Associated With Development of Muscle-Invasive Bladder Cancer.
Li J; Lou Y; Li S; Sheng F; Liu S; Du E; Zhang Z
Front Mol Biosci; 2020; 7():598599. PubMed ID: 33604353
[TBL] [Abstract][Full Text] [Related]
31. Molecular network-based identification of competing endogenous RNAs in bladder cancer.
Jiang WD; Yuan PC
PLoS One; 2019; 14(8):e0220118. PubMed ID: 31369587
[TBL] [Abstract][Full Text] [Related]
32. Thrombospondin-4 promotes bladder cancer cell migration and invasion via MMP2 production.
Chou KY; Chang AC; Ho CY; Tsai TF; Chen HE; Chen PC; Hwang TI
J Cell Mol Med; 2021 Jun; 25(13):6046-55. PubMed ID: 34142438
[TBL] [Abstract][Full Text] [Related]
33. Prognostic Value of Immune-Related Genes in the Tumor Microenvironment of Bladder Cancer.
Li F; Teng H; Liu M; Liu B; Zhang D; Xu Z; Wang Y; Zhou H
Front Oncol; 2020; 10():1302. PubMed ID: 32850407
[TBL] [Abstract][Full Text] [Related]
34. Molecular Progression Risk Score for Prediction of Muscle Invasion in Primary T1 High-Grade Bladder Cancer.
Kang HW; Seo SP; Byun YJ; Piao XM; Kim YH; Jeong P; Ha YS; Kim WT; Kim YJ; Lee SC; Moon SK; Choi YH; Yun SJ; Kim WJ
Clin Genitourin Cancer; 2018 Aug; 16(4):274-280. PubMed ID: 29571585
[TBL] [Abstract][Full Text] [Related]
35. Expression and potential prognostic value of histone family gene signature in breast cancer.
Xie W; Zhang J; Zhong P; Qin S; Zhang H; Fan X; Yin Y; Liang R; Han Y; Liao Y; Yu X; Long H; Lv Z; Ma C; Yu F
Exp Ther Med; 2019 Dec; 18(6):4893-4903. PubMed ID: 31772649
[TBL] [Abstract][Full Text] [Related]
36. Phospho-Akt pathway activation and inhibition depends on N-cadherin or phospho-EGFR expression in invasive human bladder cancer cell lines.
Wallerand H; Cai Y; Wainberg ZA; Garraway I; Lascombe I; Nicolle G; Thiery JP; Bittard H; Radvanyi F; Reiter RR
Urol Oncol; 2010; 28(2):180-8. PubMed ID: 19070520
[TBL] [Abstract][Full Text] [Related]
37. MAN1B1 is associated with poor prognosis and modulates proliferation and apoptosis in bladder cancer.
Wang HF; Wu JH; Gai JW; Yang SQ; Ma QT; Ma HS; Feng Q
Gene; 2018 Dec; 679():314-319. PubMed ID: 30218751
[TBL] [Abstract][Full Text] [Related]
38. Analysis of Autoantibodies Related to Tumor Progression in Sera from Patients with High-grade Non-muscle-invasive Bladder Cancer.
Minami S; Matsumoto K; Nagashio R; Hagiuda D; Fukuda E; Goshima N; Hattori M; Tsuchiya B; Hachimura K; Jiang SX; Saegusa M; Iwamura M; Sato Y
Anticancer Res; 2017 Dec; 37(12):6705-6714. PubMed ID: 29187447
[TBL] [Abstract][Full Text] [Related]
39. Predictive value of β-catenin in bladder cancer: a systematic review and meta-analysis.
Ren J; Yang Y; Peng T; Xu D
Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32797169
[TBL] [Abstract][Full Text] [Related]
40. Cell-type-specific CD73 expression is an independent prognostic factor in bladder cancer.
Koivisto MK; Tervahartiala M; Kenessey I; Jalkanen S; Boström PJ; Salmi M
Carcinogenesis; 2019 Mar; 40(1):84-92. PubMed ID: 30395172
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
